USANA Receivables Turnover from 2010 to 2024

USNA Stock  USD 38.04  1.88  4.71%   
USANA Health's Receivables Turnover is increasing over the years with very volatile fluctuation. Receivables Turnover is expected to dwindle to 131.05. From 2010 to 2024 USANA Health Receivables Turnover quarterly data regression line had arithmetic mean of  149.54 and r-squared of  0. View All Fundamentals
 
Receivables Turnover  
First Reported
2010-12-31
Previous Quarter
159.21
Current Value
131.05
Quarterly Volatility
30.95145886
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check USANA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USANA Health's main balance sheet or income statement drivers, such as Interest Expense of 175.4 K, Total Revenue of 585.9 M or Gross Profit of 475.7 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0 or PTB Ratio of 2.58. USANA financial statements analysis is a perfect complement when working with USANA Health Valuation or Volatility modules.
  
Check out the analysis of USANA Health Correlation against competitors.

Latest USANA Health's Receivables Turnover Growth Pattern

Below is the plot of the Receivables Turnover of USANA Health Sciences over the last few years. It is USANA Health's Receivables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in USANA Health's overall financial position and show how it may be relating to other accounts over time.
Receivables Turnover10 Years Trend
Very volatile
   Receivables Turnover   
       Timeline  

USANA Receivables Turnover Regression Statistics

Arithmetic Mean149.54
Geometric Mean145.11
Coefficient Of Variation20.70
Mean Deviation22.24
Median165.64
Standard Deviation30.95
Sample Variance957.99
Range107
R-Value0.05
Mean Square Error1,029
R-Squared0
Significance0.86
Slope0.34
Total Sum of Squares13,412

USANA Receivables Turnover History

2024 131.05
2023 159.21
2022 138.44
2016 59.03
2012 165.64
2011 102.85
2010 161.75

About USANA Health Financial Statements

USANA Health stakeholders use historical fundamental indicators, such as USANA Health's Receivables Turnover, to determine how well the company is positioned to perform in the future. Although USANA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in USANA Health's assets and liabilities are reflected in the revenues and expenses on USANA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USANA Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Receivables Turnover 159.21  131.05 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out the analysis of USANA Health Correlation against competitors.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.83
Revenue Per Share
45.085
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0809
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.